Home
Almirall

Almirall Market Share Analysis for June 2026

Almirall is a global pharmaceutical company dedicated to medical dermatology, collaborating with leading scientists, healthcare professionals and patients.

Health > Biotechnology and Pharmaceuticals

Domainalmirall.com

Year Founded1943

Employees1001 - 5000

Annual Revenue> $1B

Almirall

Almirall (including company regionals)

almirall.com

See more website traffic and engagement information

Almirall Revenue up to June 2026 is > 1B

revenue generated by Almirall top domains

Almirall top domains revenue over 3 years

Revenue for Almirall top domains

almirall.com> 1B

See more with Sales Intelligence

Almirall Stock price in June 2026

Almirall stock is traded under the ticker #ALM. Below you can review Almirall stock performance in the past 12 months up to June 2026

Total visits to Almirall's top domains

Understand Almirall market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

almirall.com92.6K

See more with Sales Intelligence

Avg. visit duration in Almirall's top domains

Analyze Almirall engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

almirall.com00:00:43

See more with Sales Intelligence

Avg. pageviews on Almirall's top domains

See how Almirall keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

almirall.com1.84

See more with Sales Intelligence

Almirall top competitors by domain

Top similar sites in June 2026, ranked by their affinity

botox.comCompany NameBotoxEmployees1001 - 5000HQUnited States, West Virginia, BarboursvilleAnnual revenue> $1BTotal visits54KHealth > Pharmacy

Top technologies used by Almirall

These are the website technologies, by industry, used by Almirall top domains

Advertising (6)

DoubleClick

Audio Video Media (4)

YouTube

Content Management System (2)

Atlassian Cloud

Conversion & Analytics (2)

Google Analytics

More Technologies

11

See all

News & Signals from Almirall

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlmirall is developing novel monoclonal antibody for medical dermatology on May 27th '26.Frankfurt, May 27, 2026 - McDermott Will & Schulte advised Spanish biopharmaceutical company Almirall, S.A. on entering into a collaboration with Chinese company Huaota Biopharmaceutical Co., Ltd., a subsidiary of Zhejiang Huahai Pharmaceutical Co., Ltd., for the development of a novel monoclonal antibody for medical dermatology.

NewsAlmirall attends event Champions For Change Gala.Almirall is participating in the Champions For Change Gala as a supporter.

NewsAlmirall partnered with BSC Fusion Group on Nov 5th '23.Almirall and Barcelona Supercomputing Center expand their collaboration to accelerate innovation in medical dermatology.